Legal Opinion
Urman v. Novelos Therapeutics, Inc.
District Court, D. Massachusetts
Decided June 11, 2012No. Civil Action No. 10-10394-NMGPublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM & ORDER
GORTON, District Judge.
This is a putative federal securities class action brought pursuant to the Securities Exchange Act of 1934 (“Exchange Act”) on behalf of individuals who purchased or otherwise acquired the common stock of Novelos Therapeutics, Inc. (“Novelos”) between December 14, 2009, and February 24, 2010 (“the Class Period”). This Court dismissed the Amended Complaint without prejudice on June 23, 2011. Before the Court is defendants’ motion to dismiss the Second Amended Complaint.
I. Background
A. The Defendants
Novelos is a biopharmaceutical company specializing in…
2Cases cited13 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
- Lormand v. US Unwired, Inc.Court of Appeals for the Fifth Circuit · 2009
8 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Coyne v. Metabolix, Inc.District Court, D. Massachusetts · 2013
- Miller Inv. Trust v. Morgan Stanley & Co.District Court, District of Columbia · 2018
- Tharp v. Acacia Commc'ns, Inc.District Court, District of Columbia · 2018
- Miller Investment Trust v. Morgan Stanley & Co. IncorporatedDistrict Court, D. Massachusetts · 2018
- Tharp v. Acacia Communications, Inc.District Court, D. Massachusetts · 2018